1259 related articles for article (PubMed ID: 6707926)
1. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
4. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
5. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
[TBL] [Abstract][Full Text] [Related]
7. Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
Cavero I
Clin Exp Hypertens A; 1982; 4(1-2):221-33. PubMed ID: 7074987
[TBL] [Abstract][Full Text] [Related]
8. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
Solomon RE; Brody MJ; Gebhart GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
Harland D; Brown MJ
J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
14. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
16. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
[TBL] [Abstract][Full Text] [Related]
18. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
[TBL] [Abstract][Full Text] [Related]
19. [The effects of nicergoline on the heart rate in the normotensive or spontaneously hypertensive rat. Possible participation of central alpha-1 receptors].
Huchet AM; Schmitt H
J Pharmacol; 1986; 17(1):53-9. PubMed ID: 3012204
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
